Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 178 of 1,261
  1. US 11723929

    Methods of improving cell-based therapy

    The Regents of the University of California Β· Granted Aug 15, 2023 Β· Expires Aug 10, 2043

    granted
  2. US 11725008

    Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

    The Board of Regents of the University of Texas System Β· Granted Aug 15, 2023 Β· Expires Aug 10, 2043

    granted
  3. CA 3235923

    PROCEDES DE SYNTHESE A GRANDE ECHELLE DE COMPLEXES DE RADIONUCLEIDES

    ADVANCED ACCELERATOR APPLICATIONS [FR] Β· Granted Aug 10, 2023 Β· Expires Aug 5, 2043

    granted
  4. US 11718576

    Compositions and methods comprising resveratrol

    Biocogent, LLC Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  5. US 11717576

    Antibody-immune agonist conjugate and applications thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  6. US 11718596

    Amyloid targeting agents and methods of using the same

    The Regents of the University of California Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  7. US 11718616

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Theravance Biopharma R&D IP, LLC Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  8. US 11718655

    Masked interleukin-12 polypeptides

    Xilio Development, Inc. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  9. US 11718612

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  10. US 11717565

    Recombinant BCG overexpressing phoP-phoR

    LTD. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  11. US 11717558

    Nucleic acid molecules encoding activin receptor type IIA variants

    Keros Therapeutics, Inc. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  12. US 11717542

    Using tumor-navigating Salmonella to modulate tumor metabolism

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  13. US 11717553

    Combined plant extract for getting rid of mites and acne and preparation method and use thereof

    Nanjing Institute for Comprehensive Utilization of Wild Plants, All China Federation of Supply and Marketing Corporation Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  14. US 11718665

    Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins

    Rani Therapeutics, LLC Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  15. US 11717573

    Methods and compositions for the treatment of cancer

    SOUTH DAKOTA BOARD OF REGENTS Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  16. US 11717547

    Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

    Krystal Biotech, Inc. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  17. US 11717480

    Extracellular vesicles and methods and uses thereof

    The Regents of the University of California Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  18. US 11718647

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  19. US 11718852

    Non-liposomal systems for nucleic acid delivery

    ARBUTUS BIOPHARMA CORPORATION Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  20. US 11718834

    Compositions and methods for producing recombinant AAV

    Sangamo Therapeutics, Inc. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  21. US 11718679

    CD137 antibodies and PD-1 antagonists and uses thereof

    Compass Therapeutics LLC Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  22. US 11718658

    T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

    MiNK Therapeutics, Inc. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  23. US 11718621

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted
  24. US 11718613

    N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Aug 8, 2023 Β· Expires Aug 3, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.